Calcium channel blockers for primary Raynaud's phenomenon: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Calcium Channel Blockers for Primary Raynaud's Phenomenon: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440137/all/Comparison_of_routes_for_achieving_parenteral_access_with_a_focus_on_the_management_of_patients_with_Ebola_virus_disease_Edited__no_change_to_conclusions_. Accessed 25 April 2024.
Calcium channel blockers for primary Raynaud's phenomenon: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440137/all/Comparison_of_routes_for_achieving_parenteral_access_with_a_focus_on_the_management_of_patients_with_Ebola_virus_disease_Edited__no_change_to_conclusions_. Accessed April 25, 2024.
Calcium channel blockers for primary Raynaud's phenomenon: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/440137/all/Comparison_of_routes_for_achieving_parenteral_access_with_a_focus_on_the_management_of_patients_with_Ebola_virus_disease_Edited__no_change_to_conclusions_
Calcium Channel Blockers for Primary Raynaud's Phenomenon: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440137/all/Comparison_of_routes_for_achieving_parenteral_access_with_a_focus_on_the_management_of_patients_with_Ebola_virus_disease_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Calcium channel blockers for primary Raynaud's phenomenon: Cochrane systematic review
ID - 440137
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440137/all/Comparison_of_routes_for_achieving_parenteral_access_with_a_focus_on_the_management_of_patients_with_Ebola_virus_disease_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -